1 / 1
klow40 (40mg) is a high-purity research peptide formulated as a lyophilized powder, designed for advanced studies in metabolic regulation and energy balance. Modeled after Retatrutide, it functions as a triple receptor agonist targeting GLP-1, GIP, and glucagon pathways, making it a subject of interest in research related to obesity, glucose metabolism, and fat oxidation.
This compound typically appears as a white to off-white powder with a purity of ≥99% (HPLC), supplied in a sterile vial containing 40mg.
It is intended for laboratory reconstitution under controlled conditions and should be stored at low temperatures to maintain stability.
klow40 is strictly classified as a Research Use Only (RUO) substance. It is not approved for human or veterinary use and must not be used for diagnostic or therapeutic purposes. As with similar compounds under ongoing investigation, its safety profile and long-term effects remain under study.
klow40 (40mg) is a high-purity research peptide formulated as a lyophilized powder, modeled after Retatrutide for advanced studies in metabolic regulation and energy balance.
It functions as a triple receptor agonist targeting GLP-1, GIP, and glucagon pathways.
It is primarily studied in research related to obesity, glucose metabolism, and fat oxidation.
It typically appears as a white to off-white powder with a purity of ≥99% (HPLC), supplied in a sterile vial containing 40mg.
It is intended for laboratory reconstitution under controlled conditions and must be stored at low temperatures to maintain stability.
No, klow40 is strictly classified as a Research Use Only (RUO) substance. It is not approved for human or veterinary use, nor for diagnostic or therapeutic purposes.
